IDEXX Laboratories Inc. revenue by year
Over the 10 fiscal years shown, revenue went from $1.78B (year ended Dec 31, 2016) to $4.30B (year ended Dec 31, 2025), a compound annual growth rate of 10.3%. The fastest growth was +18.8% in the year ended Dec 31, 2021; the weakest year was +4.7% (year ended Dec 31, 2022).
Annual revenue
| Fiscal year ended | Revenue (USD) | Change | XBRL concept | Reported in |
|---|---|---|---|---|
| Dec 31, 2025 | $4.30B | +10.4% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 20, 2026 |
| Dec 31, 2024 | $3.90B | +6.5% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 20, 2026 |
| Dec 31, 2023 | $3.66B | +8.7% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 20, 2026 |
| Dec 31, 2022 | $3.37B | +4.7% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 21, 2025 |
| Dec 31, 2021 | $3.22B | +18.8% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 22, 2024 |
| Dec 31, 2020 | $2.71B | +12.5% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 16, 2023 |
| Dec 31, 2019 | $2.41B | +8.8% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 16, 2022 |
| Dec 31, 2018 | $2.21B | +12.4% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 12, 2021 |
| Dec 31, 2017 | $1.97B | +10.9% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 14, 2020 |
| Dec 31, 2016 | $1.78B | +10.8% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 15, 2019 |
Quarterly revenue
Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.
| Quarter | Revenue (USD) | vs same quarter a year earlier | Source |
|---|---|---|---|
| 3 months ended Sep 30, 2026 | $1.21B | +9.9% | 10-Q filed Nov 2, 2026 |
| 3 months ended Jun 30, 2026 | $1.22B | +9.7% | 10-Q filed Aug 4, 2026 |
| 3 months ended Mar 31, 2026 | $1.14B | +14.3% | 10-Q filed May 5, 2026 |
| 3 months ended Sep 30, 2025 | $1.11B | +13.3% | 10-Q filed Nov 2, 2026 |
| 3 months ended Jun 30, 2025 | $1.11B | +10.6% | 10-Q filed Aug 4, 2026 |
| 3 months ended Mar 31, 2025 | $998.43M | +3.6% | 10-Q filed May 5, 2026 |
| 3 months ended Sep 30, 2024 | $975.54M | +6.6% | 10-Q filed Nov 3, 2025 |
| 3 months ended Jun 30, 2024 | $1.00B | +6.4% | 10-Q filed Aug 4, 2025 |
Source: SEC EDGAR XBRL company facts for CIK 874716 (raw data). Most recent filing in this dataset: 10-Q filed Nov 2, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.